The Patent Finder

CysBio ApS

9 patents currently held · Updated Nov 14, 2026
1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Jul 2035
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Jun 24, 2027
    The maintenance fee for Method for the production of L-serine using genetically engineered microorganisms deficient in serine degradation pathways (US 10,513,682) comes due Jun 24, 2027. Unpaid by Dec 27, 2027, it lapses early.
  • 1 fee due Sep 17, 2027
    The maintenance fee for Process for producing a fermentation product from a lignocellulose-containing material (US 10,590,440) comes due Sep 17, 2027. Unpaid by Mar 17, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 9 of 9

PatentTitleStatus Expires Confidence
US 10,752,923Processes for the production of hydroxycinnamic acids using polypeptides having tyrosine ammonia lyase activity
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,306,331Processes for the production of hydroxycinnamic acids using polypeptides having tyrosine ammonia lyase activity
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,590,440Process for producing a fermentation product from a lignocellulose-containing material
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,390,894Biological processes for the production of aryl sulfates
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,793,826Genetically modified microorganisms having improved tolerance towards L-serine
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,407,976Genetically modified microorganisms having improved tolerance towards L-serine
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,513,682Method for the production of L-serine using genetically engineered microorganisms deficient in serine degradation pathways
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,954,536Modified Escherichia coli having an increased expression of a CysP transporter, an ATP sulfurylase, an APS kinase and a PAP phosphatase
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,555,212Process for the production of sulfated phenolic compounds using modified Escerichia coli
In force
 · From the USPTO record
In forceFrom the USPTO record
Also on record, not counted in the 9: 1 patent in force now held by others. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

Every application published under this name has become a patent.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited